- Home
- SCSC vs CDNA Comparison
SCSC vs CDNA Comparison
Compare SCSC & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCSC
- CDNA
- Stock Information
- Founded
- SCSC 1992
- CDNA 1998
- Country
- SCSC United States
- CDNA United States
- Employees
- SCSC N/A
- CDNA N/A
- Industry
- SCSC Retail: Computer Software & Peripheral Equipment
- CDNA Medical Specialities
- Sector
- SCSC Technology
- CDNA Health Care
- Exchange
- SCSC Nasdaq
- CDNA Nasdaq
- Market Cap
- SCSC 732.8M
- CDNA 1.0B
- IPO Year
- SCSC 1994
- CDNA 2014
- Fundamental
- Price
- SCSC $42.12
- CDNA $20.51
- Analyst Decision
- SCSC Hold
- CDNA Buy
- Analyst Count
- SCSC 1
- CDNA 6
- Target Price
- SCSC N/A
- CDNA $30.33
- AVG Volume (30 Days)
- SCSC 195.1K
- CDNA 908.5K
- Earning Date
- SCSC 08-26-2025
- CDNA 07-30-2025
- Dividend Yield
- SCSC N/A
- CDNA N/A
- EPS Growth
- SCSC N/A
- CDNA N/A
- EPS
- SCSC 2.78
- CDNA 1.07
- Revenue
- SCSC $2,974,037,000.00
- CDNA $346,421,000.00
- Revenue This Year
- SCSC N/A
- CDNA $13.31
- Revenue Next Year
- SCSC $4.96
- CDNA $15.46
- P/E Ratio
- SCSC $15.17
- CDNA $17.91
- Revenue Growth
- SCSC N/A
- CDNA 25.92
- 52 Week Low
- SCSC $28.75
- CDNA $14.09
- 52 Week High
- SCSC $53.90
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- SCSC 58.61
- CDNA 62.23
- Support Level
- SCSC $41.84
- CDNA $18.37
- Resistance Level
- SCSC $43.33
- CDNA $19.84
- Average True Range (ATR)
- SCSC 0.96
- CDNA 0.78
- MACD
- SCSC -0.07
- CDNA -0.00
- Stochastic Oscillator
- SCSC 62.73
- CDNA 84.56
About SCSC ScanSource Inc.
ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Modern Communications and Cloud. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.